Obesity-Driven Disruption of Hematopoiesis and the Bone Marrow Niche|
This review discusses the differentiation and function of hematopoietic cell populations, the principal physicochemical components of the bone marrow niche, and how this environment influences hematopoietic stem cells and hematopoiesis in general. [Nat Rev Endocrinol] Abstract
Visit our reviews page to see a complete list of reviews in the hematopoiesis research field.
Bio-Path Holdings Successfully Completes Cohort 6 of Phase I Clinical Trial Evaluating Liposomal Grb-2 in Blood Cancers|
Bio-Path Holdings, Inc. announced that it has successfully completed Cohort 6 of its Phase I clinical trial evaluating lead compound, Liposomal Grb-2, in blood cancers. [Bio-Path Holdings, Inc.] Press Release
FDA Approves VELCADE® (Bortezomib) for Injection for Previously Untreated Patients with Mantle Cell Lymphoma
Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited, announced that the U.S. Food and Drug Administration (FDA) has approved VELCADE® for injection for use in previously untreated patients with mantle cell lymphoma. [Takeda Pharmaceutical Company Limited]
Actinobac Biomed Receives $905,000 Small Business Grant from NCI to Advance Blood Cancer Research
Actinobac Biomed Inc., has received a $905,040 small business technology transfer grant Phase II award from the National Institutes of Health/National Cancer Institute (NCI) to continue to develop its drug candidate, Leukothera®, as a potential treatment for B-cell lymphomas. [Actinobac Biomed Inc. (PR Newswire Association LLC)] Press Release
Amgen’s BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation in Acute Lymphoblastic Leukemia
Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted for review the biologics license application for the investigational bispecific T cell engager (BiTE®) antibody construct, blinatumomab. [Amgen] Press Release
From our sponsor: Free mouse hematopoietic progenitors wallchart. Request your copy.